Comment
doi: 10.1513/AnnalsATS.201503-114LE.
Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration
Affiliations
- PMID: 26075561
- DOI: 10.1513/AnnalsATS.201503-114LE
Item in Clipboard
Comment
Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration
Ann Am Thorac Soc.
2015 Jun.
No abstract available
Comment in
-
Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.Ann Am Thorac Soc. 2015 Jun;12(6):960. doi: 10.1513/AnnalsATS.201505-263LE. Ann Am Thorac Soc. 2015. PMID: 26075562 No abstract available.
Comment on
-
Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.Ann Am Thorac Soc. 2015 Feb;12(2):269-73. doi: 10.1513/AnnalsATS.201501-020AS. Ann Am Thorac Soc. 2015. PMID: 25590376
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
